Literature DB >> 30016889

An evaluation of the diagnostic methods in head and neck cancer of unknown primary site.

Katri Aro1, Leif Bäck1, Antti Mäkitie1,2, Laura Tapiovaara1.   

Abstract

BACKGROUND: Various detection methods to identify the primary in head and neck cancer of unknown primary (HN-CUP) require evaluation to improve and standardize management.
OBJECTIVES: To evaluate the use of different diagnostic methods, which aim at decreasing the incidence of HN-CUP.
MATERIAL AND METHODS: We conducted a retrospective analysis of patients with HN-CUP at the Helsinki University Hospital during 1995-2011. We evaluated clinical assessment, definitive treatment, histopathology, and follow up. We analyzed the success in identifying the primary site to show any changes in diagnostic methods over time.
RESULTS: Frequency of HN-CUP and success in identifying the primary site have remained constant despite the addition of PET-CT and determination of human papilloma virus (HPV) status in diagnostics. Among 133 patients, the diagnostic work up identified the primary site in 53% and the oropharynx predominated (69%). This left 85 patients with HN-CUP and 5-year overall and disease-free survival rates were 71 and 69%, respectively.
CONCLUSIONS: Panendoscopy including tonsillectomy should not be omitted in the work up. SIGNIFICANCE: We demonstrate a steady frequency of HN-CUP and constant success in identifying the primary site. Detection of a primary later in the follow up did not impact the survival.

Entities:  

Keywords:  Diagnostics; head and neck cancer; metastasis; survival; unknown primary

Mesh:

Year:  2018        PMID: 30016889     DOI: 10.1080/00016489.2018.1484567

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  3 in total

1.  Standardized Diagnostics Including PET-CT Imaging, Bilateral Tonsillectomy and Neck Dissection Followed by Risk-Adapted Post-Operative Treatment Favoring Radio-Chemotherapy Improve Survival of Neck Squamous Cell Carcinoma of Unknown Primary Patients.

Authors:  Gunnar Wichmann; Maria Willner; Thomas Kuhnt; Regine Kluge; Tanja Gradistanac; Theresa Wald; Sandra Fest; Florian Lordick; Andreas Dietz; Susanne Wiegand; Veit Zebralla
Journal:  Front Oncol       Date:  2021-05-07       Impact factor: 6.244

Review 2.  Metastatic Squamous Cell Carcinoma to the Cervical Lymph Nodes From an Unknown Primary Cancer: Management in the HPV Era.

Authors:  Francisco J Civantos; Jan B Vermorken; Jatin P Shah; Alessandra Rinaldo; Carlos Suárez; Luiz P Kowalski; Juan P Rodrigo; Kerry Olsen; Primoz Strojan; Antti A Mäkitie; Robert P Takes; Remco de Bree; June Corry; Vinidh Paleri; Ashok R Shaha; Dana M Hartl; William Mendenhall; Cesare Piazza; Michael Hinni; K Thomas Robbins; Ng Wai Tong; Alvaro Sanabria; Andres Coca-Pelaz; Johannes A Langendijk; Juan Hernandez-Prera; Alfio Ferlito
Journal:  Front Oncol       Date:  2020-11-10       Impact factor: 6.244

Review 3.  Human Papillomavirus and Squamous Cell Carcinoma of Unknown Primary in the Head and Neck Region: A Comprehensive Review on Clinical Implications.

Authors:  Mikkel Hjordt Holm Larsen; Hani Ibrahim Channir; Christian von Buchwald
Journal:  Viruses       Date:  2021-07-02       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.